ACTAVIS Group has partnered with QRxPharma Limited to launch a patented 3:2 ratio fixed dose combination of morphine and oxycodone, MoxDuo, into the US$2.5 billion American acute pain market. MoxDuo is now expected to hit the US market in the third quarter of 2012.
THE Pharmacy Board of Australia has opened public consultation on the draft registration standards and guidelines for a proposed Endorsement for scheduled medicines for pharmacists.
AS the Federal Government enters final negotiations for the First Pharmacy Programs Agreement (1PPA), the Remote and Isolated Pharmacist Association Australia (RIPAA) is calling for a dedicated funding pilot to support resident clinical pharmacists in Australia’s most isolated communities.
UK-BASED organisation GenM founder Heather Jackson (pictured) is on a mission to support pharmacies helping women through menopause with its MTick certification and accreditation.